Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0001470831-26-000701

President and COO sold 28,750 shares at an average $28.98 ($833,129)

  • President and COO acquired 18,750 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohlhepp Ryan President and COO 2026-07-08 Option exercise 10b5-1 +18,750 $3.79 $71,059 210,391 D: show line 1 in the form
Cohlhepp Ryan President and COO 2026-07-08 Sale 10b5-1 −22,833 $28.76 $656,652 187,558 D: show line 2 in the form
Cohlhepp Ryan President and COO 2026-07-08 Sale 10b5-1 −4,306 $29.80 $128,302 183,252 D: show line 3 in the form
Cohlhepp Ryan President and COO 2026-07-08 Sale 10b5-1 −1,075 $30.35 $32,632 182,177 D: show line 4 in the form
Cohlhepp Ryan President and COO 2026-07-09 Sale 10b5-1 −536 $29.00 $15,544 181,641 D: show line 5 in the form
Open-market sales · 28,750 sh · avg $28.98 · $833,129

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohlhepp Ryan President and COO 2026-07-08 Option exercise · Stock Option (Right to Buy) 10b5-1 −18,750 70,502 D: show line 6 in the form
Loading xslF345X06/wk-form4_1783714248.xml…